{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:20:39Z","timestamp":1791566439673,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":233,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jaut.2022.102831","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T17:54:44Z","timestamp":1650045284000},"page":"102831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-5284","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Coutant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Bachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Alonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2022.102831_bib1","doi-asserted-by":"crossref","first-page":"773352","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies","volume":"12","author":"Nombel","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102831_bib2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102831_bib3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2022.102831_bib4","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2022.102831_bib5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/03009742.2017.1340512","article-title":"Anti-MDA5-positive dermatomyositis: an emerging entity with a variable clinical presentation","volume":"46","author":"Ortiz-Santamaria","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102831_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.resinv.2018.07.007","article-title":"Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis","volume":"56","author":"Sakamoto","year":"2018","journal-title":"Respir Investig"},{"key":"10.1016\/j.jaut.2022.102831_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13075-018-1737-2","article-title":"Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis","volume":"20","author":"Ishikawa","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102831_bib8","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","article-title":"Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease","volume":"53","author":"Gono","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2022.102831_bib9","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41598-017-01685-5","article-title":"Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study","volume":"7","author":"Oda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2022.102831_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-8958-4_5","article-title":"An efficient method to generate monoclonal antibodies from human B cells","volume":"1904","author":"Guthmiller","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jaut.2022.102831_bib11","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.3390\/ijms222011095","article-title":"Impact of host immune status on discordant anti-SARS-CoV-2 circulating B cell frequencies and antibody levels","volume":"22","author":"Coutant","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2022.102831_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.175.3.671","article-title":"Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A","volume":"175","author":"Defrance","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102831_bib13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10067-020-05339-2","article-title":"Hierarchical cluster analysis of cytokine profiles reveals a cutaneous vasculitis-associated subgroup in dermatomyositis","volume":"40","author":"Bai","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102831_bib14","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/rheumatology\/kez525","article-title":"Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-\u03b1 signalling","volume":"59","author":"Melki","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2022.102831_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fmed.2020.00077","article-title":"Interstitial lung disease-complicated anti-MDA5 antibody in clinically amyopathic dermatomyositis patients: report of two cases with distinct clinical features","volume":"7","author":"Pacot","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2022.102831_bib16","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.rmed.2015.07.004","article-title":"Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis","volume":"109","author":"Takada","year":"2015","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2022.102831_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1073\/pnas.022637199","article-title":"mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties","volume":"99","author":"Kang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2022.102831_bib18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","article-title":"Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum","volume":"65","author":"Hall","year":"2013","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2022.102831_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cyto.2014.10.014","article-title":"Interferon gamma in autoimmunity: a complicated player on a complex stage","volume":"74","author":"Lees","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2022.102831_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10875-005-4092-4","article-title":"mRNA quantification of T-bet, GATA-3, IFN-gamma, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: link with disease activity","volume":"25","author":"Kawashima","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2022.102831_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2004.022731","article-title":"Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity","volume":"64","author":"Kawashima","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102831_bib22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1006\/bbrc.2002.6487","article-title":"Cytotoxicity of IFN-gamma and TNF-alpha for vascular endothelial cell is mediated by nitric oxide","volume":"291","author":"Yamaoka","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2022.102831_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.trsl.2010.11.007","article-title":"Synergistic induction of CX3CL1 by interleukin-1\u03b2 and interferon-\u03b3 in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways","volume":"157","author":"Isozaki","year":"2011","journal-title":"Transl. Res."},{"key":"10.1016\/j.jaut.2022.102831_bib24","doi-asserted-by":"crossref","first-page":"16833","DOI":"10.1038\/s41598-017-17007-8","article-title":"Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration","volume":"7","author":"Ishida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2022.102831_bib25","first-page":"37","article-title":"Inhaled interferon and diffusion capacity in idiopathic pulmonary fibrosis (IPF)","volume":"32","author":"Skaria","year":"2015","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2022.102831_bib26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/kez357","article-title":"Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy","volume":"59","author":"Abe","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2022.102831_bib27","article-title":"Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: a case report","volume":"97","author":"Endo","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2022.102831_bib28","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10067-020-05530-5","article-title":"Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy","volume":"40","author":"Ge","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102831_bib29","first-page":"5386797","article-title":"Effective administration of rituximab in anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease and refractory cutaneous involvement: a case report and literature Review","volume":"2017","author":"Ogawa","year":"2017","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.jaut.2022.102831_bib30","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s10067-018-4122-2","article-title":"Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis","volume":"37","author":"So","year":"2018","journal-title":"Clin. Rheumatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:29:00Z","timestamp":1760257740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":30,"alternative-id":["S0896841122000397"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102831","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102831"}}